According to ImmunoGen 's latest financial reports the company's current earnings are A$0.28 Billion. In 2022 the company made an earning of -A$0.35 Billion a decrease over its 2021 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -A$90.13 Million | -73.49% |
2022 | -A$0.35 Billion | 72.45% |
2021 | -A$0.2 Billion | 495.9% |
2020 | -A$33.09 Million | -75.71% |
2019 | -A$0.14 Billion | -44.88% |
2018 | -A$0.25 Billion | 99.42% |
2017 | -A$0.13 Billion | |
2015 | -A$0.17 Billion | 43.7% |
2014 | -A$0.12 Billion | 135.39% |
2013 | -A$48.21 Million | -66.03% |
2012 | -A$0.15 Billion | 42.86% |
2011 | -A$99.31 Million | 16.68% |
2010 | -A$85.12 Million | 32.83% |
2009 | -A$64.09 Million | -1.99% |
2008 | -A$65.39 Million | 108.61% |
2007 | -A$31.35 Million | -10.13% |
2006 | -A$34.88 Million | 28.86% |
2005 | -A$27.07 Million | 120.33% |
2004 | -A$12.29 Million | -61.19% |
2003 | -A$31.65 Million | -16.6% |
2002 | -A$37.95 Million | 51.86% |
2001 | -A$24.99 Million | |
1999 | A$1.4 M | -112.68% |
1998 | -A$11.1 Million | -13.41% |
1997 | -A$12.82 Million | -10.87% |
1996 | -A$14.38 Million | -35.66% |
1995 | -A$22.36 Million | -19.21% |
1994 | -A$27.67 Million | -14.49% |
1993 | -A$32.36 Million | 23.95% |
1992 | -A$26.11 Million | |
1989 | -A$10.95 Million |